Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02457962

Enrollment

15000

Registered

2015-05-29

Start date

2015-04-23

Completion date

2031-04-30

Last updated

2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Malignancies, Solid Tumors

Brief summary

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology 2. Radiation therapy for curative intent

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame
analyze acute and late toxicities using CTCAE 4.03	Patients will be followed for the duration of their life, an expected average of 20 years
analyze quality of life using LASA-3 and FACT-E	Patients will be followed for the duration of their life, an expected average of 20 years

Secondary

Measure	Time frame
analyze local control through tumor assessments	Patients will be followed for the duration of their life, an expected average of 20 years
analyze survival by contacting patient and EMR (electronic medical record) review	Patients will be followed for the duration of their life, an expected average of 20 years

Countries

United States

Contacts

CONTACTClinical Trials Referral Office

mayocliniccancerstudies@mayo.edu855-776-0015

PRINCIPAL_INVESTIGATORNadia N. Laack, MD

Mayo Clinic

Outcome results